Soluble Interleukin-2 Receptors in B-Cell Leukemia and the Acquired Immunodeficiency Syndrome
Authors: CARMEN MEDINA-IBARRONDO
Journal: Annals of Internal Medicine (1987)

Letters and Corrections1 May 1987Soluble Interleukin-2 Receptors in B-Cell Leukemia and the Acquired Immunodeficiency SyndromeCARMEN MEDINA-IBARRONDO, M.D., JUAN JOSE LAHUERTA-PALACIOS, M.D., MANUEL LAHUERTA-PALACIOS, M.D.CARMEN MEDINA-IBARRONDO, M.D.Search for more papers by this author, JUAN JOSE LAHUERTA-PALACIOS, M.D.Search for more papers by this author, MANUEL LAHUERTA-PALACIOS, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-106-5-774 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: In the NIH conference on the human interleukin-2 receptor (1), it is reported that interleukin-2 receptors in adult T-cell leukemia are overexpressed by the leukemic cells. It has also been reported (1, 2) that the interleukin-2 receptor is expressed not only on T lymphocytes but also on B lymphocytes and natural killer cells. Stimulated lymphocytes not only express on their surface interleukin-2 receptors but also produce soluble interleukin-2 receptors (3).We have found soluble interleukin-2 receptors in the nondiluted serum of two groups of patients. The first group included eight patients, aged 51 to 65 years, with...References1. GREENELEONARDDEPPERNELSONWALDMANN WWJDT. The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med. 1986;105:560-72. LinkGoogle Scholar2. SHIRAKAWATANAKAETO FYS. Effect of interleukin-1 on the expression of interleukin-2 receptor (TAC antigen) on human natural killer-like cell line (YT cells). J Immunol. 1986;137:551-6. MedlineGoogle Scholar3. WAGNERYORK-JOLLEYMALEKBERZOGSKYNELSON AJTJD. Antigen specific murine T cell clones produce soluble interleukin-2 receptor on stimulation with specific antigens. J Immunol. 1986;137:592-6. MedlineGoogle Scholar4. CATOVSKYO'BRIENMELOWARDIEBROZOVIC DMJJM. Hairy cell leukaemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukaemia. Semin Oncol. 1984;11:362-9. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: CARMEN MEDINA-IBARRONDO, M.D.; JUAN JOSE LAHUERTA-PALACIOS, M.D.; MANUEL LAHUERTA-PALACIOS, M.D.Affiliations: Hospital Provincial and 1°Octubre 28009 Madrid, Spain PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySoluble Interleukin-2 Receptor Levels and Immune Activation in Patients with Schistosomiasis and Carcinoma of the Urinary BladderT-cell chronic lymphocytic leukemia: T-cell function and lymphokine secretionImmunological studies in HIV seronegative haemophiliacs: relationships to blood product therapySerum Soluble Interleukin-2 Receptor Levels are Associated with Clinical Disease Status and Histopathological Grade in Non-Hodgkin's Lymphoma and Chronic Lymphocytic LeukemiaSerum Soluble Interleukin-2 Receptor Levels in Hairy Cell Leukemia: Correlation with Clinical and Hematological Parameters and with α-Interferon TreatmentHematopoietic growth factor receptorsSerum Soluble Interleukin-2 Receptor Levels in Patients with Adult T-cell Leukemia and Human T-cell Leukemia/Lymphoma Virus Type-I Seropositive Healthy CarriersTHE SOLUBLE INTERLEUKIN-2 RECEPTOR IN HAEMATOLOGICAL DISORDERS 1 May 1987Volume 106, Issue 5Page: 774-774KeywordsAIDSB cellsCellsLymphocytesNatural killer cellsT cell receptors ePublished: 1 December 2008 Issue Published: 1 May 1987 PDF downloadLoading ...